Dupixent (dupilumab) is a brand-name injection that’s prescribed for treating asthma. This article covers topics such as side effects, dosage, and how Dupixent works. Dupixent is available as a ...

Dupixent (dupilumab) is a brand-name injectable drug ... Dupixent syringe are used to give Dupixent doses by subcutaneous injection. Dupixent pen and syringe share several features but also ...

Global healthcare company Sanofi and Regeneron Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injection to patients suffering from ...

Dupixent (dupilumab) was the first biologic treatment ... Most people are able to give themselves the injection after they learn how. The injection is typically given into a fatty area around ...

Dupixent (dupilumab) is tipped to be the market leader ... The IL-4 and IL-13 targeting antibody is administered as a subcutaneous injection every other week after an initial loading dose, and ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

Sanofi has upped its revenue forecasts for the year on the back of strong second quarter results from its new eczema and asthma injection ... said that sales of Dupixent (dupilumab) were up ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...

Dupixent ® (dupilumab) is now used to treat over a million patients globally. The recent approval and launch in chronic obstructive pulmonary disease (COPD) has had a successful start ...